|
ACE/Angiotension receptors
Citations 121-130 of 225 total displayed.
|
Past content
(since Jun 1999):
|
- Basic Science Reports
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
- Chao-Hung Wang, Shu-Hong Li, Richard D. Weisel, Paul W.M. Fedak, Aaron S. Dumont, Paul Szmitko, Ren-Ke Li, Donald A.G. Mickle, and Subodh Verma
Circulation 2003;107:1783-1790; published online before print as doi:10.1161/01.CIR.0000061916.95736.E5
[Abstract]
[Full text]
- Articles
Vasopeptidase Inhibitor Omapatrilat Induces Profound Insulin Sensitization and Increases Myocardial Glucose Uptake in Zucker Fatty Rats. Studies Comparing a Vasopeptidase Inhibitor, Angiotensin-Converting Enzyme Inhibitor, and Angiotensin II Type I Receptor Blocker
- Chao-Hung Wang, Nathalie Leung, Nathalie Lapointe, Linda Szeto, Kristine D. Uffelman, Adria Giacca, Jean L. Rouleau, and Gary F. Lewis
Circulation published March 31, 2003, doi:10.1161/01.CIR.0000062646.09566.CC
[Abstract]
- Basic Science Reports
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
- Chao-Hung Wang, Shu-Hong Li, Richard D. Weisel, Paul W.M. Fedak, Aaron S. Dumont, Paul Szmitko, Ren-Ke Li, Donald A.G. Mickle, and Subodh Verma
Circulation published March 17, 2003, doi:10.1161/01.CIR.0000061916.95736.E5
[Abstract]
[Full text]
- Clinical Investigations and Reports
Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin
- Mias Pretorius, David Rosenbaum, Douglas E. Vaughan, and Nancy J. Brown
Circulation 2003;107:579-585; published online before print as doi:10.1161/01.CIR.0000046268.59922.A4
[Abstract]
[Full text]
- Special Review: Clinical Cardiology: New Frontiers
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging
- Edward G. Lakatta
Circulation 2003;107:490-497, doi:10.1161/01.CIR.0000048894.99865.02
[Full text]
- Articles
Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin
- Mias Pretorius, David Rosenbaum, Douglas E. Vaughan, and Nancy J. Brown
Circulation published January 27, 2003, doi:10.1161/01.CIR.0000046268.59922.A4
[Abstract]
- Basic Science Reports
Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation
- Masatsugu Horiuchi, Tai-Xing Cui, Zhen Li, Jian-Mei Li, Hironori Nakagami, and Masaru Iwai
Circulation 2003;107:106-112; published online before print as doi:10.1161/01.CIR.0000043244.13596.20
[Abstract]
[Full text]
- Articles
Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation
- Masatsugu Horiuchi, Tai-Xing Cui, Zhen Li, Jian-Mei Li, Hironori Nakagami, and Masaru Iwai
Circulation published December 9, 2002, doi:10.1161/01.CIR.0000043244.13596.20
[Abstract]
- Correspondence
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats • Response
- John McMurray, Andrew P. Davie, Annemarieke E. Loot, Anton J.M. Roks, Robert H. Henning, Wiek H. van Gilst, René A. Tio, Albert J.H. Suurmeyer, and Frans Boomsma
Circulation 2002;106:e147, doi:10.1161/01.CIR.0000037125.61227.68
[Full text]
- Basic Science Reports
Perivascular Superoxide Anion Contributes to Impairment of Endothelium-Dependent Relaxation: Role of gp91phox
- Federico E. Rey, Xiao-Chun Li, Oscar A. Carretero, Jeffrey L. Garvin, and Patrick J. Pagano
Circulation 2002;106:2497-2502; published online before print as doi:10.1161/01.CIR.0000038108.71560.70
[Abstract]
[Full text]
|
|
